Skip to main content

The Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma

  • Chapter
Cancer of the Liver, Esophagus, and Nasopharynx
  • 44 Accesses

Abstract

Shortly after the discovery of the Epstein-Barr virus (EBV) in cultured Burkitt’s lymphoma (BL) cells, the association of the virus with another human malignant disease became apparent. Old et al. [21] noted first that patients with nasopharyngeal carcinoma (NPC) have unusually high antibody titers against viral antigens. This finding has since been widely confirmed and extended (for review, see [7, 10]). NPC is characterized by particular epidemiological features. It is the most frequent cancer in adult males in some parts of south China, with an age peak between 45 and 55 years. It occurs, however, with a lesser frequency all over the world. The Mediterranean countries are known as areas with an intermediate risk. Remarkably, there is a second peak at the age of 10–20 years for the occurrence of NPC outside China.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersson-Anvret M, Forsby N, Klein G, Henle W: Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int. J. Cancer 20 (1977) 486–494

    Article  PubMed  CAS  Google Scholar 

  2. Bayliss GJ, Wolf H: An Epstein-Barr virus early protein induces cell fusion. Proc. Natl. Acad. Sei. USA 78 (1981) 7162–7165

    Article  CAS  Google Scholar 

  3. Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA: Comparison of Epstein-Barr virus strains of different origin by analysis of viral DNAs. J. Virol. 35 (1980) 603–618

    PubMed  CAS  Google Scholar 

  4. Brichacek B, Hirsch I, Sibl O, Vilikusova E, Vonka V: Association of some supraglottic laryngeal carcinomas with EB virus. Int. J. Cancer 32 (1983) 193–197

    Article  PubMed  CAS  Google Scholar 

  5. Brichacek B, Hirsch I, Sibl O, Vilikusova E, Vonka V: Presence of Epstein-Barr virus DNA in carcinoma of the palatine tonsil. J. Natl. Cancer Inst. 72 (1984) 809 - 811

    PubMed  CAS  Google Scholar 

  6. Crawford DH, Epstein MA, Bornkamm GW, Achong BG, Finerty S, Thompson JL: Bio-logical and biochemical properties of isolates of Epstein-Barr virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int. J. Cancer 24 (1979) 294–302

    Article  PubMed  CAS  Google Scholar 

  7. Epstein MA, Achong BG (eds): The Epstein-Barr virus. Springer Verlag, Berlin-Heidelberg-New York 1979

    Google Scholar 

  8. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK: Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313 (1985) 1564–1571

    Article  PubMed  CAS  Google Scholar 

  9. Henle G, Henle W: Epstein-Barr virus-specific Ig A serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17 (1976) 1–17

    Article  PubMed  CAS  Google Scholar 

  10. Henle W, Henle G: Epstein-Barr virus and human malignancies. In: Advances in Viral Oncology, Vol.5, Klein G (ed), Raven Press, New York (1985) 201–238

    Google Scholar 

  11. Henle W, Ho JHC, Henle G, Chan JCW, Kwan HC: Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int. J. Cancer 20 (1977) 663–672

    Article  PubMed  CAS  Google Scholar 

  12. Ho JHC, Kwan HC, Ng MN, de Thé G: Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma cells. Lancet 1 (1978) 436

    Article  PubMed  CAS  Google Scholar 

  13. Huang DP, Ho JHC, Henle W, Henle G: Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int. J. Cancer 14 (1974) 580–588

    Article  PubMed  CAS  Google Scholar 

  14. Kaschka-Dierich C, Adams A, Lindahl T, Bornkamm GW, Bjursell G, Klein G: Intracel¬lular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature 260 (1976) 302–306

    Article  PubMed  CAS  Google Scholar 

  15. Krueger GRF, Wustrow J: Current histological classification of nasopharyngeal carcinoma (NPC) at Cologne University. In: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma, Grundmann E, Krueger GRF, Ablashi DV (eds), Gustav Fischer Verlag, Stuttgart-New York (1981) pp. 11–16

    Google Scholar 

  16. Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, Dohan PH: Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA. Int. J. Cancer 28 (1981) 301–305

    Article  PubMed  CAS  Google Scholar 

  17. Laux G, Freese UK, Bornkamm GW: Structure and evolution of two related transcription units of Epstein-Barr virus carrying small tandem repeats. J. Virol. 56 (1985) 987–995

    PubMed  CAS  Google Scholar 

  18. Leyvraz S, Henle W, Chaninian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF: Association of Epstein-Barr virus with thymic carcinoma. New Engl. J. Med. 312 (1985) 1296–1299

    Article  PubMed  CAS  Google Scholar 

  19. Misko IS, Moss DJ, Pope JH: HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77 (1980) 4247–4250

    Article  PubMed  CAS  Google Scholar 

  20. Morgan DG, Miller G, Niederman JC, Smith HW, Dowaliby JM: Site of Epstein-Barr virus replication in the oropharynx. Lancet II (1979) 1154–1157

    Article  Google Scholar 

  21. Old LJ, Boyse EA, Oettgen HF, de Herven E, Geering G, Williams B, Clifford P: Precipitating antibody in human serums to an antigen present in cultured Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. USA 56 (1966) 1691–1704.

    Google Scholar 

  22. Raab-Traub N, Hood R, Yang C-S, Henry II B, Pagano JS: Epstein-Barr virus transcription in nasopharyngeal carcinoma. J. Virol. 48 (1983) 580–590

    PubMed  CAS  Google Scholar 

  23. Reedman B, Klein G: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11 (1973) 499–520

    Article  PubMed  CAS  Google Scholar 

  24. Rickinson AB, Wallace LE, Epstein MA: HLA-restricted T cell recognition of Epstein-Barr virus infected B cells. Nature 283 (1980) 865–867

    Article  PubMed  CAS  Google Scholar 

  25. Semundsen AK, Albeck H, Hansen JPH: Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas in Greenland Eskimoes. Br. J. Cancer 46 (1982) 721–728

    Article  Google Scholar 

  26. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS: Epstein-Barr virus replication in oropharyngeal epithelial cells. New Engl. J. Med. 310 (1984) 1225–1230

    Article  PubMed  CAS  Google Scholar 

  27. Strauch B, Andrews LL, Siegel N, Miller G: Oropharyngeal excretion of Epstein-Barr virus by renal transplant patients and other patients treated with immunosuppressive drugs. Lancet I (1974) 234–237

    Article  Google Scholar 

  28. Svedmyr E, Jondal M: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectous mononucleosis. Proc. Natl. Acad. Sci. USA 72 (1975) 1622–1626

    Article  PubMed  CAS  Google Scholar 

  29. Wolf H, zur Hausen H, Becker V: EB-viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol. 244 (1973) 245–247

    PubMed  CAS  Google Scholar 

  30. Wolf H, Haus M, Wilmes E: Persistence of Epstein-Barr virus in the parotid gland. J. Virol. 51 (1984) 795–798

    PubMed  CAS  Google Scholar 

  31. Yao QY, Rickinson AB, Gaston JSH, Epstein MA: In vitro analysis of the Epstein-Barr virus — host balance in longterm renal allograft recipients. Int. J. Cancer 35 (1985) 43–49

    Article  PubMed  CAS  Google Scholar 

  32. Zeng Y, Yuxi L, Chunren L, Sanwen C, Jihneng W, Jisong Z, Huijong Z: Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma. Intervirology 13 (1980) 162–168

    Article  Google Scholar 

  33. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228 (1970) 1056–1058

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag

About this chapter

Cite this chapter

Bornkamm, G.W. (1987). The Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma. In: Wagner, G., You-Hui, Z. (eds) Cancer of the Liver, Esophagus, and Nasopharynx. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71510-5_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71510-5_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16967-3

  • Online ISBN: 978-3-642-71510-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics